BIG PHARMAS, NOT SUCH AN ALL-WEATHER INVESTMENT
25/06/20 -"This story was first issued on 15-06-2020. ‘Valuation Wise’ takes a rest. Pre-COVID-19, holding Big Pharmas (seven issuers, €940bn market cap) would not make a big difference ..."
Pages
68
Language
English
Published on
25/06/20
You may also be interested by these reports :
06/02/26
We have updated our outdated earnings projections following the release of the group’s Q4 results. We have also added 2028 to our forecasts. As ...
06/02/26
The release of the fourth quarter results has been poorly received. Not only were the results fully in line with expectations, but the fine-tuned ...
06/02/26
Danske Bank’s Q4 results significantly beat consensus, driven by resilient NII and robust fee income growth. A 13.3% RoE and 100% FY-25 total ...
05/02/26
BNP Paribas’ Q4 2025 results featured an underlying pre-tax beat, driven by CPBS recovery and AXA IM integration. The bank over-delivered on cost ...